Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CFTR | P13569 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30319508 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP2A6CYP3A4CYP1A2CFTR | |
| SCHEMBL15652709 | 0.97 | ALDH1A1 (0.48) | ALDH1A1CYP2A6CYP3A4CYP1A2CFTR | |
| SCHEMBL25620250 | 0.93 | CYP3A4 (0.57) | ALDH1A1CYP2A6CYP3A4CYP1A2CFTR | |
| SCHEMBL617213 | 0.93 | CYP3A4 (0.57) | ALDH1A1CYP2A6CYP3A4CYP1A2CFTR | |
| SCHEMBL9623856 | 0.85 | ALDH1A1 (0.42) | ALDH1A1CYP2A6CYP3A4CYP1A2TDP1 | |
| SCHEMBL19797424 | 0.82 | TDP1 (0.44) | ALDH1A1CYP2A6CYP3A4CYP1A2CFTR | |
| SCHEMBL9624369 | 0.82 | CYP19A1 (0.47) | ALDH1A1CYP3A4CYP1A2KDM4EALOX15 | |
| SCHEMBL9624006 | 0.80 | KMT2A (0.47) | ALDH1A1CYP3A4CYP1A2KDM4EMAPT | |
| SCHEMBL12620100 | 0.79 | — | — | |
| SCHEMBL29143382 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311793-B | Catalyst and process for producing aldehyde | 伊士曼化工公司 | 2022-03-22 | — | — | CN | claimed |
| EP-3475252-B1 | CATALYSTS AND PROCESSES FOR PRODUCING ALDEHYDES | EASTMAN CHEM CO (US) | 2021-04-14 | — | — | EP | claimed |
| EP-2855413-B1 | CATALYSTS AND PROCESSES FOR PREPARING ALDEHYDES | EASTMAN CHEM CO (US) | 2018-07-25 | — | — | EP | claimed |
| EP-2855412-B1 | CATALYSTS AND PROCESS FOR PRODUCING ALDEHYDES | EASTMAN CHEM CO (US) | 2018-04-18 | — | — | EP | claimed |
| EP-2855414-B1 | CATALYST AND METHOD HAVING IMPROVED SELECTIVITY TO ISOBUTYRALDEHYDE VIA CATLAYST INDUCTION | EASTMAN CHEM CO (US) | 2017-03-29 | — | — | EP | claimed |
| EP-4155288-B1 | METHOD FOR IMPROVED CONTROL OF ISOMERIC RATIOS IN HYDROFORMYLATIONS | OXEA GMBH (DE) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024103456-A1 | CATALYST FOR HYDROFORMYLATION OF OLEFINS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国海洋石油集团有限公司 | 2024-05-23 | — | — | WO | disclosed |
| US-11981688-B2 | Methods of preparing cytotoxic benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| US-11981687-B2 | Methods of preparing cytotoxic benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| EP-4361128-A2 | METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES | ImmunoGen, Inc. (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117916216-A | Method for improving control of isomer ratio in hydroformylation reactions | OQ化学有限责任公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-3880681-B1 | METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES | IMMUNOGEN INC (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-1257531-A2 | METHOD FOR THE PREPARATION OF CARBOTHIOIC ACIDS | Abbott Laboratories (US) | 2002-11-20 | — | — | EP | disclosed |
| US-20020133032-A1 | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods | ABBOTT LABORATORIES | 2002-09-19 | — | — | US | disclosed |
| US-20020091107-A1 | Oxazolidinone antibacterial agents | ABBOTT LABORATORIES | 2002-07-11 | — | — | US | disclosed |
| WO-2002032919-A2 | 6-O-SUBSTITUTED ERYTHROMYCIN DERIVATIVES HAVING IMPROVED GASTROINTESTINAL TOLERANCE | ABBOTT LABORATORIES (US) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002020515-A1 | OXAZOLIDINONE ANTIBACTERIAL AGENTS | ABBOTT LABORATORIES (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2001077134-A2 | PROCESS FOR THE PREPARATION OF 6-O-PROPARGYL ERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 2001-10-18 | — | — | WO | disclosed |
| WO-2001062722-A2 | METHOD FOR THE PREPARATION OF FLUTICASONE AND RELATED 17BETA-CARBOTHIOIC ESTERS USING A NOVEL CARBOTHIOIC ACID SYNTHESIS AND NOVEL PURIFICATION METHODS | ABBOTT LABORATORIES (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-1996017856-A1 | SYNTHESIS OF BIDENTATE PHOSPHINES | GRIFFITH UNIVERSITY (AU) | 1996-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981687-B2 | Methods of preparing cytotoxic benzodiazepine derivatives | GABRA3, GABRA5, GABRA6 | ALDH1A1 2186/4885CYP2A6 189/4885CYP3A4 40/4885 |
| US-11981688-B2 | Methods of preparing cytotoxic benzodiazepine derivatives | GABRA3, GABRA5, GABRA6 | ALDH1A1 2186/4885CYP2A6 189/4885CYP3A4 40/4885 |
| US-20020133032-A1 | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods | HSD17B7, CYP17A1, NR5A1 | ALDH1A1 1653/4885CYP2A6 82/4885CYP3A4 148/4885 |
| US-20020091107-A1 | Oxazolidinone antibacterial agents | OXA1L, TOP1, MT-ND1 | ALDH1A1 297/4885CYP2A6 901/4885CYP3A4 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.